Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ferlini

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Cardiology|July 28, 2022
Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysisFederico Oliveri, Claudio Montalto, Lorenzo Tua, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 24, 2020
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'?Alberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
European Journal of Preventive Cardiology|December 17, 2019
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionAlberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
International Journal of Cardiology|November 7, 2022
RESPONSE TO LETTER TO THE EDITOR - "DOACs versus VKAs were associated with lower odds of all-cause mortality and similar odds of major bleeding"Federico Oliveri, Montalto Claudio, Lorenzo Tua, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2020
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes?Andrea Demarchi, Stefano Cornara, Alberto Somaschini, et al.
The Canadian Journal of Cardiology|August 5, 2019
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel DiseaseFederico Fortuni, Gabriele Crimi, Filippo Angelini, et al.
The American Journal of Cardiology|September 4, 2017
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary InterventionStefano Cornara, Alberto Somaschini, Stefano De Servi, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 6, 2019
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and plateletsAlberto Somaschini, Andrea Demarchi, Stefano Cornara, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarctionAlessandro Mandurino-Mirizzi, Andrea Demarchi, Marta Ruffinazzi, et al.
Circulation. Cardiovascular Interventions|May 31, 2019
Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary InterventionMarco Ferlini, Roberta Rossini, Giuseppe Musumeci, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Cardiology|July 28, 2022
Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysisFederico Oliveri, Claudio Montalto, Lorenzo Tua, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 24, 2020
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'?Alberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
European Journal of Preventive Cardiology|December 17, 2019
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionAlberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
International Journal of Cardiology|November 7, 2022
RESPONSE TO LETTER TO THE EDITOR - "DOACs versus VKAs were associated with lower odds of all-cause mortality and similar odds of major bleeding"Federico Oliveri, Montalto Claudio, Lorenzo Tua, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2020
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes?Andrea Demarchi, Stefano Cornara, Alberto Somaschini, et al.
The Canadian Journal of Cardiology|August 5, 2019
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel DiseaseFederico Fortuni, Gabriele Crimi, Filippo Angelini, et al.
The American Journal of Cardiology|September 4, 2017
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary InterventionStefano Cornara, Alberto Somaschini, Stefano De Servi, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 6, 2019
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and plateletsAlberto Somaschini, Andrea Demarchi, Stefano Cornara, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarctionAlessandro Mandurino-Mirizzi, Andrea Demarchi, Marta Ruffinazzi, et al.
Circulation. Cardiovascular Interventions|May 31, 2019
Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary InterventionMarco Ferlini, Roberta Rossini, Giuseppe Musumeci, et al.
Pageof 15